Quick Answer
Medicus Pharma Ltd. reported Net Income Loss of -$47.28 million for the year ending 2025.
- Medicus Pharma Ltd. showed a decrease of -323.8% in Net Income Loss from 2024 to 2025.
- This data is from Medicus Pharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: -$1.71 million | Q3 2024: -$2.28 million | Q1 2025: -$5.10 million | Q3 2025: -$20.94 million.
- Over the full 3 years of available data (2023 to 2025), Medicus Pharma Ltd.'s Net Income Loss has declined by 789.6%.
- Historical annual values: Fiscal year 2025: -$47.28 million | Fiscal year 2024: -$11.16 million | Fiscal year 2023: -$5.31 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: